After Detroit Lions lifer Tracy Scroggins died at 56, his family was quick to blame his NFL playing career for the "untimely" nature of his death. Scroggins' family suspects chronic traumatic ...

Boston University researchers in a groundbreaking study found that those with CTE have a much higher chance of being diagnosed with dementia. The largest study of its kind from the Boston University ...

Stage III or IV chronic traumatic encephalopathy (CTE) pathology was associated with increased odds of dementia in a large autopsy study. The study assessed brain donors with CTE pathology and no ...

The largest study of its kind from the Boston University CTE Center reveals that chronic traumatic encephalopathy (CTE) should be recognized as a new cause of dementia. The research, published online ...

Patients with advanced chronic traumatic encephalopathy (CTE), a brain disease likely caused by repeated head injuries, were more than four times as likely to develop dementia compared to those ...

Recursive language models (RLMs) are an inference technique developed by researchers at MIT CSAIL that treat long prompts as an external environment to the model. Instead of forcing the entire prompt ...

Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with content, and download exclusive resources. Cory Benfield discusses the evolution of ...

CHICAGO (WLS) -- Football players are among the professional athletes at highest risk for developing a neurodegenerative disease known as CTE. Currently, it can only be identified during an autopsy, ...

(TNS) — There is a surge of interest in career and technical education programs at the secondary school level, fueled by concerns about the cost of college and opportunities to make good money in jobs ...

There is a surge of interest in career and technical education programs at the secondary school level, fueled by concerns about the cost of college and opportunities to make good money in jobs that ...

Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...

Recursion Pharmaceuticals Inc (NASDAQ: RXRX) shares moved higher Wednesday after JPMorgan upgraded the stock to Overweight from Neutral and lifted its price target to $11 from $10. What Happened: ...